Skip to content

Newer-generation balloon-expandable vs. self-expanding transcatheter aortic valves: a propensity score matched analysis.

Aug 2026 · Journal of Cardiovascular Medicine · Vol 27 9, pp. 706-715 · 1 citation · 30 references
Medicine

TL;DR

Among patients treated with newer-generation transcatheter valves, SEV demonstrated more favorable hemodynamic performance compared with BEV, however, short- and mid-term mortality rates remained similar between the two groups.

Abstract

Aims

Balloon-expandable valve (BEV) and self-expanding valve (SEV) platforms have undergone significant technological advancements. This study aimed to compare postoperative outcomes in patients with severe aortic stenosis (AS) treated with transcatheter aortic valve implantation (TAVI) using newer-generation BEV and SEV devices.

Methods

We retrospectively analyzed all patients who underwent TAVI for severe native AS at a single center between January 2018 and December 2023. Exclusion criteria included emergency procedures, active endocarditis, prior aortic valve interventions, bicuspid valves, primary aortic regurgitation, non-transfemoral access, concomitant coronary procedures, and use of retracted valves. Bioprosthetic valve dysfunction (BVD) was assessed according to modified Valve Academic Research Consortium 3 (VARC-3) definitions.

Results

Propensity score matching was used to create 354 well balanced pairs. Periprocedural outcomes, including mortality, were comparable between the matched BEV and SEV groups. However, echocardiographic evaluation at discharge revealed significantly higher mean transvalvular gradients (P < 0.001) and peak velocities (P < 0.001) in the BEV group. During follow-up, the SEV group showed a significantly lower incidence of BVD [hazard ratio (HR): 0.64, 95% confidence interval (CI): 0.45-0.91; P = 0.013], particularly regarding higher rates of severe prosthesis-patient mismatch (P = 0.001) and at least moderate structural valve deterioration (P = 0.006). No significant differences were observed in all-cause (HR: 1.18, 95% CI: 0.90-1.56, P = 0.235), or cardiac-related mortality (HR: 1.29, 95% CI: 0.91-1.83, P = 0.157).

Conclusion

Among patients treated with newer-generation transcatheter valves, SEV demonstrated more favorable hemodynamic performance compared with BEV. However, short- and mid-term mortality rates remained similar between the two groups. Longer-term follow-up of randomized trials is needed to confirm these findings.

View source

Similar papers

Oct 2026

Current Generation Self-Expanding and Balloon-Expandable Transcatheter Aortic Valve Replacement: A Retrospective Multicenter Analysis.

BACKGROUND Evolving transcatheter aortic valve replacement (TAVR) technology warrants updated comparisons of the most commonly used current generation self-expanding (SE) versus balloon-expandable (BE) transcatheter heart valves (THV). METHODS This 9-center retrospective analysis stratified patients undergoing TAVR f...

Emily C. Scheffel, Kristin Putman, Lauryn A. Ridley et al. · 0 citations
Sep 2026

Long-term outcomes after balloon- or self-expandable transcatheter aortic valve replacement in small aortic annuli.

The need for further investigations using larger cohorts and contemporary devices to validate long-term comparative outcomes of BEV and SEV in patients with SAA is underscore the need for further investigations using larger cohorts and contemporary devices to validate long-term comparative outcomes.

T. Ryuzaki, Kentaro Hayashida, Kei Kamata et al. · 0 citations
Review Open access Sep 2026

Balloon-Expandable Versus Self-Expandable Transcatheter Aortic Valve Implantation Devices: A Contemporary Systematic Review

Background/Objectives: Transcatheter aortic valve implantation (TAVI) is an established treatment for severe aortic stenosis. Prosthesis selection is increasingly important because balloon-expandable valves (BEVs) and self-expandable valves (SEVs) differ in deployment, hemodynamics, and lifetime-management implications...

I. Apergis, Georgios P. Georghiou, Panos Georghiou et al. · 0 citations
Open access Feb 2026

Transcatheter aortic valve-in-valve implantation for failed surgical aortic bioprostheses using the Navitor platform: early outcomes in a consecutive single-center cohort

Introduction Transcatheter heart valve implantation into a failed surgical heart valve (THV-in-SHV) is an established reintervention strategy for degenerated aortic bioprostheses; however, early procedural outcomes, discharge hemodynamics, and standardized safety remain clinically relevant in routine practice. Material...

R. Sobczyński, J. Trębacz, Paweł Kleczyński et al. · 0 citations
Oct 2026

Impact of prolonged balloon inflation on valve expansion and early clinical outcomes following contemporary balloon-expandable transcatheter aortic valve implantation.

BACKGROUND Incomplete expansion of balloon-expandable (BE) transcatheter heart valves (THVs) after transcatheter aortic valve implantation (TAVI) may affect valve performance and durability. Routine THV post-dilatation (the "double-tap" technique) has been proposed to optimise device expansion; however, it may increase...

F. Cardaioli, L. N. Fovino, T. Fabris et al. · 0 citations
Open access Aug 2026

Early Multicenter Outcomes of Dedicated Transcatheter Aortic Valve Replacement for Left Ventricular Assist Device‐Associated Pure Aortic Regurgitation

ABSTRACT Background Aortic regurgitation (AR) is a frequent and clinically relevant complication in patients with left ventricular assist devices (LVAD), impairing circulatory support and worsening outcomes. Surgical aortic valve replacement often carries prohibitive risk in this population, while conventional transcat...

H. Hinkov, Sara Yousefzada, I. Just et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.